Oxford Global is proud to present the 2nd Oncology Biomarkers Congress. It is to be co-located with our Oncology Clinical Development Congress. Over the 2 days, the event provides a first class educational and networking opportunity for over 150 attendees to gain knowledge and insights into the Oncology biomarkers market.
The event will bring together key scientists whose expertise is focused on biomarkers, companion diagnostics, personalized medicine, safety studies, translational medicine and decision making in the oncology therapeutic area, from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe. This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.